Biotechnology
The Biotechnology industry has a total of 601 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.3 billion.
Market Cap
1.11T
Revenue
105.3B
Profits
-41.51B
PE Ratio
n/a
Profit Margin
-39.42%
Dividend Yield
0.04%
601 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.16B | 0.16% | 1,811,348 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.29B | 0.10% | 789,671 | 14.25B |
| 3 | ARGX | argenx SE | 49.24B | 1.20% | 494,233 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 46.97B | -1.04% | 1,722,436 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 36.99B | -1.16% | 272,358 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.87B | 1.29% | 2,656,761 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.49B | -3.16% | 946,733 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.56B | -1.16% | 3,669,769 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.47B | -3.38% | 5,311,103 | - |
| 10 | INCY | Incyte Corporation | 20.15B | -3.38% | 2,205,699 | 4.81B |
| 11 | GMAB | Genmab A/S | 19.33B | -2.85% | 2,764,701 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 16.80B | 2.80% | 12,608,989 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.98B | -0.65% | 4,192,164 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.88B | 1.22% | 2,977,305 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.23B | 4.74% | 677,830 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.56B | 1.57% | 4,894,318 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.38B | -5.75% | 3,210,922 | - |
| 18 | EXEL | Exelixis, Inc. | 11.79B | -0.41% | 1,645,234 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.47B | 0.65% | 222,653 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.92B | -0.07% | 948,367 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.84B | 1.30% | 2,278,266 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.82B | 3.15% | 3,344,372 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.20B | -0.90% | 840,279 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.48B | 1.49% | 1,989,865 | 6.23M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.30B | 4.08% | 1,280,878 | 561.26M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.99B | 2.15% | 502,892 | 7.46M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.97B | 2.26% | 1,415,250 | 829.45M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.28B | -1.10% | 915,961 | 1.24B |
| 29 | NUVL | Nuvalent, Inc. | 8.23B | 1.60% | 511,831 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.97B | -3.62% | 428,577 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.80B | 1.92% | 1,454,011 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.41B | -1.90% | 2,583,814 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.85B | 0.94% | 932,583 | 174.33M |
| 34 | IBRX | ImmunityBio, Inc. | 6.38B | 17.39% | 210,958,093 | 82.56M |
| 35 | GPCR | Structure Therapeutics Inc. | 6.29B | 2.69% | 1,871,976 | - |
| 36 | PCVX | Vaxcyte, Inc. | 6.22B | 2.00% | 1,310,028 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 6.07B | 2.47% | 1,786,134 | - |
| 38 | BLTE | Belite Bio, Inc | 6.00B | 3.16% | 133,958 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.87B | 0.81% | 1,104,064 | 1.78B |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.71B | -0.54% | 1,015,851 | 1.54M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.54B | 1.57% | 618,671 | - |
| 42 | KYMR | Kymera Therapeutics, Inc. | 5.45B | -2.01% | 1,024,515 | 43.74M |
| 43 | IMVT | Immunovant, Inc. | 5.30B | -0.49% | 1,328,224 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.22B | 1.74% | 901,263 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.01B | -1.68% | 1,809,809 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.88B | -1.47% | 869,585 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.75B | 0.92% | 579,730 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.56B | -0.51% | 1,079,138 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.52B | 1.21% | 2,362,471 | 531.90M |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | 1.15% | 1,248,470 | 1.05B |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.43B | -0.14% | 4,097,385 | 598.70M |
| 52 | CGON | CG Oncology, Inc. | 4.41B | -0.07% | 922,036 | 2.17M |
| 53 | LEGN | Legend Biotech Corporation | 4.33B | 5.78% | 4,844,635 | 909.05M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.19B | 1.62% | 1,862,482 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 4.17B | 4.69% | 2,417,260 | 35.90M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 3.98B | -0.05% | 1,354,746 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.87B | 1.87% | 184,018 | 251.23M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.79B | -1.18% | 2,222,968 | - |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.71B | 1.61% | 1,620,483 | 741.17M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | 2.40% | 653,818 | 35.24M |
| 61 | LQDA | Liquidia Corporation | 3.42B | 3.77% | 2,008,935 | 69.22M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.35B | 3.24% | 638,908 | 15.00M |
| 63 | ALMS | Alumis Inc. | 3.25B | 9.22% | 2,809,193 | 22.12M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.21B | 3.78% | 738,841 | 7.50M |
| 65 | VERA | Vera Therapeutics, Inc. | 3.18B | -3.61% | 1,567,909 | - |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.17B | 0.08% | 995,288 | 317.93M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.13B | -0.25% | 549,142 | 214.83M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.12B | -1.86% | 1,300,939 | 70.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.06B | -0.82% | 1,606,275 | 55.70M |
| 70 | EWTX | Edgewise Therapeutics, Inc. | 3.04B | 4.89% | 2,034,349 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 3.01B | -0.30% | 734,021 | 366.10M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.87B | 3.00% | 1,620,880 | 578.20M |
| 73 | IRON | Disc Medicine, Inc. | 2.79B | 4.33% | 466,683 | - |
| 74 | ERAS | Erasca, Inc. | 2.78B | 1.98% | 7,302,053 | - |
| 75 | DNLI | Denali Therapeutics Inc. | 2.74B | -2.56% | 1,414,142 | - |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.73B | -0.78% | 2,069,889 | - |
| 77 | ADPT | Adaptive Biotechnologies Corporation | 2.73B | 2.00% | 2,119,630 | 252.75M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.72B | 0.69% | 731,613 | 240.00M |
| 79 | IMNM | Immunome, Inc. | 2.63B | 6.56% | 2,027,101 | 9.68M |
| 80 | TLX | Telix Pharmaceuticals Limited | 2.62B | -0.39% | 148,476 | 664.23M |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.62B | 1.47% | 596,880 | - |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.59B | 2.66% | 2,785,189 | 1.02B |
| 83 | WVE | Wave Life Sciences Ltd. | 2.53B | 1.25% | 2,975,285 | 109.23M |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.53B | -2.47% | 1,174,687 | - |
| 85 | TVTX | Travere Therapeutics, Inc. | 2.50B | 0.25% | 1,305,077 | 435.83M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.44B | 1.60% | 3,539,973 | 55.78M |
| 87 | AAPG | Ascentage Pharma Group International | 2.40B | -3.84% | 4,193 | 54.52M |
| 88 | SLNO | Soleno Therapeutics, Inc. | 2.35B | 2.94% | 1,366,264 | 98.68M |
| 89 | RXRX | Recursion Pharmaceuticals, Inc. | 2.29B | -5.78% | 22,280,268 | 43.69M |
| 90 | MESO | Mesoblast Limited | 2.21B | -3.55% | 326,231 | 17.20M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -0.43% | 1,740,232 | 2.41B |
| 92 | GLPG | Galapagos NV | 2.18B | -0.06% | 230,277 | 336.64M |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | 0.62% | 2,275,602 | 630.60M |
| 94 | MAZE | Maze Therapeutics, Inc. | 2.13B | 8.76% | 546,315 | 2.50M |
| 95 | ZLAB | Zai Lab Limited | 2.10B | 1.78% | 588,859 | 441.63M |
| 96 | OLMA | Olema Pharmaceuticals, Inc. | 2.10B | -1.55% | 844,869 | - |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | -0.86% | 719,855 | 825.94M |
| 98 | NUVB | Nuvation Bio Inc. | 2.06B | 2.74% | 10,411,680 | 26.75M |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 2.00B | 5.67% | 1,021,708 | 3.08M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.40% | 1,118,151 | 265.81M |
| 101 | MBX | MBX Biosciences, Inc. | 1.94B | 6.44% | 765,483 | - |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 1.94B | 3.08% | 1,283,426 | 181.54M |
| 103 | ARDX | Ardelyx, Inc. | 1.89B | 14.96% | 15,777,609 | 398.23M |
| 104 | NRIX | Nurix Therapeutics, Inc. | 1.85B | -5.05% | 1,637,007 | 83.69M |
| 105 | VCEL | Vericel Corporation | 1.84B | -2.97% | 460,489 | 258.72M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.79B | 2.30% | 155,242 | - |
| 107 | ZYME | Zymeworks Inc. | 1.77B | 0.85% | 644,677 | 134.48M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -1.41% | 1,080,887 | 111.30M |
| 109 | PHVS | Pharvaris N.V. | 1.70B | 4.46% | 105,754 | - |
| 110 | MNKD | MannKind Corporation | 1.69B | 5.37% | 5,251,182 | 313.79M |
| 111 | TNGX | Tango Therapeutics, Inc. | 1.68B | -3.84% | 4,188,809 | 66.50M |
| 112 | IMCR | Immunocore Holdings plc | 1.68B | -0.06% | 393,880 | 379.59M |
| 113 | BHVN | Biohaven Ltd. | 1.68B | -3.50% | 2,817,652 | - |
| 114 | UPB | Upstream Bio, Inc. | 1.68B | - | 773,856 | 2.80M |
| 115 | CLDX | Celldex Therapeutics, Inc. | 1.67B | -1.99% | 456,992 | 2.60M |
| 116 | DFTX | Definium Therapeutics, Inc. | 1.65B | 11.50% | 3,680,180 | - |
| 117 | KOD | Kodiak Sciences Inc. | 1.65B | -1.88% | 733,409 | - |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.64B | 0.07% | 888,003 | 205.63M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.61B | -0.51% | 451,387 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.61B | 1.27% | 1,011,888 | - |
| 121 | CRVS | Corvus Pharmaceuticals, Inc. | 1.60B | 165.96% | 83,966,504 | - |
| 122 | RAPT | RAPT Therapeutics, Inc. | 1.60B | 64.02% | 31,928,311 | - |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.58B | 2.57% | 1,642,716 | - |
| 124 | AGIO | Agios Pharmaceuticals, Inc. | 1.56B | -1.88% | 895,832 | 44.79M |
| 125 | PGEN | Precigen, Inc. | 1.55B | -0.45% | 3,012,979 | 6.31M |
| 126 | OCS | Oculis Holding AG | 1.50B | 3.09% | 503,955 | 992.00K |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.49B | 2.64% | 9,590,357 | 57.53M |
| 128 | FTRE | Fortrea Holdings Inc. | 1.46B | -4.12% | 1,440,516 | 2.76B |
| 129 | INVA | Innoviva, Inc. | 1.46B | 0.57% | 505,637 | 388.52M |
| 130 | SVRA | Savara Inc. | 1.44B | 2.58% | 1,231,648 | - |
| 131 | ATAI | AtaiBeckley Inc. | 1.40B | 5.77% | 5,783,561 | 3.02M |
| 132 | QURE | uniQure N.V. | 1.40B | -1.93% | 1,315,820 | 15.75M |
| 133 | TRVI | Trevi Therapeutics, Inc. | 1.34B | -0.57% | 1,680,786 | - |
| 134 | NVAX | Novavax, Inc. | 1.33B | 2.37% | 11,870,549 | 1.06B |
| 135 | IMTX | Immatics N.V. | 1.32B | 0.41% | 271,075 | 99.45M |
| 136 | EYPT | EyePoint, Inc. | 1.29B | 3.05% | 1,024,961 | 42.34M |
| 137 | RLAY | Relay Therapeutics, Inc. | 1.28B | 0.82% | 3,500,217 | 8.36M |
| 138 | DBVT | DBV Technologies S.A. | 1.28B | 0.53% | 725,520 | 5.50M |
| 139 | ANAB | AnaptysBio, Inc. | 1.28B | 1.16% | 315,396 | 169.47M |
| 140 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | 1.75% | 3,379,771 | 6.31M |
| 141 | XERS | Xeris Biopharma Holdings, Inc. | 1.26B | 1.20% | 1,880,120 | 266.14M |
| 142 | CAPR | Capricor Therapeutics, Inc. | 1.25B | -0.62% | 2,086,763 | 11.13M |
| 143 | ABCL | AbCellera Biologics Inc. | 1.25B | 0.97% | 3,869,213 | 35.33M |
| 144 | DAWN | Day One Biopharmaceuticals, Inc. | 1.24B | 19.19% | 7,045,484 | 133.67M |
| 145 | RAPP | Rapport Therapeutics, Inc. | 1.24B | -3.13% | 225,779 | - |
| 146 | SANA | Sana Biotechnology, Inc. | 1.22B | - | 3,043,824 | - |
| 147 | SEPN | Septerna, Inc. | 1.21B | 3.59% | 159,817 | 22.05M |
| 148 | PHAR | Pharming Group N.V. | 1.20B | -2.82% | 37,787 | 362.27M |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.17B | -2.57% | 2,120,294 | - |
| 150 | PVLA | Palvella Therapeutics, Inc. | 1.16B | -1.72% | 119,857 | - |
| 151 | IVA | Inventiva S.A. | 1.15B | -1.23% | 791,023 | 19.93M |
| 152 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -4.13% | 1,821,136 | - |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.12B | 3.57% | 721,619 | 15.00M |
| 154 | PHAT | Phathom Pharmaceuticals, Inc. | 1.11B | 0.64% | 950,437 | 147.19M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.06B | 0.87% | 233,605 | 1.40M |
| 156 | TBPH | Theravance Biopharma, Inc. | 1.03B | 2.05% | 298,424 | 80.33M |
| 157 | SPRY | ARS Pharmaceuticals, Inc. | 1.03B | -1.69% | 1,205,141 | 142.77M |
| 158 | CMPX | Compass Therapeutics, Inc. | 1.02B | 0.18% | 1,022,772 | 850.00K |
| 159 | NBTX | Nanobiotix S.A. | 1.01B | - | 8,356 | 11.93M |
| 160 | VTYX | Ventyx Biosciences, Inc. | 995.89M | -0.07% | 2,200,027 | - |
| 161 | AKTS | Aktis Oncology, Inc. | 985.84M | -4.96% | 270,714 | 5.56M |
| 162 | GHRS | GH Research PLC | 976.96M | -7.30% | 466,311 | - |
| 163 | IOVA | Iovance Biotherapeutics, Inc. | 968.60M | 3.39% | 14,024,460 | 250.43M |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 958.90M | -4.34% | 1,181,970 | 192.44M |
| 165 | AVBP | ArriVent BioPharma, Inc. | 918.92M | 6.71% | 473,303 | - |
| 166 | ANNX | Annexon, Inc. | 918.18M | 1.48% | 1,949,747 | - |
| 167 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 916.67M | 0.35% | 299,904 | - |
| 168 | BCAX | Bicara Therapeutics Inc. | 915.95M | -0.18% | 555,220 | - |
| 169 | CTMX | CytomX Therapeutics, Inc. | 909.87M | -0.37% | 4,890,274 | 113.63M |
| 170 | URGN | UroGen Pharma Ltd. | 904.82M | 2.82% | 568,657 | 96.52M |
| 171 | XNCR | Xencor, Inc. | 902.63M | -1.17% | 812,046 | 150.13M |
| 172 | VALN | Valneva SE | 881.01M | -2.98% | 8,229 | 211.09M |
| 173 | OMER | Omeros Corporation | 869.24M | 2.08% | 2,268,208 | - |
| 174 | YDES | YD Bio Limited | 840.32M | 5.57% | 79,958 | 510.36K |
| 175 | VIR | Vir Biotechnology, Inc. | 834.75M | -0.99% | 1,688,911 | 16.86M |
| 176 | GERN | Geron Corporation | 829.86M | -0.76% | 22,752,881 | 183.40M |
| 177 | NBY | NovaBay Pharmaceuticals, Inc. | 819.07M | -55.99% | 3,422,717 | 10.30M |
| 178 | ABUS | Arbutus Biopharma Corporation | 808.72M | 3.57% | 2,571,621 | 14.61M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 802.55M | -5.68% | 272,755 | - |
| 180 | MDXG | MiMedx Group, Inc. | 798.27M | -0.55% | 1,300,229 | 393.44M |
| 181 | JANX | Janux Therapeutics, Inc. | 790.94M | -4.43% | 2,241,873 | 10.00M |
| 182 | KALV | KalVista Pharmaceuticals, Inc. | 773.86M | 4.86% | 1,255,019 | 1.43M |
| 183 | ARVN | Arvinas, Inc. | 772.62M | -1.39% | 463,290 | 312.30M |
| 184 | KURA | Kura Oncology, Inc. | 748.35M | 1.65% | 1,743,795 | 104.03M |
| 185 | MPLT | MapLight Therapeutics, Inc. | 743.21M | -0.12% | 100,116 | - |
| 186 | NKTR | Nektar Therapeutics | 736.98M | -3.85% | 759,251 | 62.60M |
| 187 | SLS | SELLAS Life Sciences Group, Inc. | 735.62M | 8.54% | 10,655,940 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 720.76M | 3.26% | 74,744 | 107.27M |
| 189 | RGNX | REGENXBIO Inc. | 713.79M | 3.52% | 902,703 | 161.32M |
| 190 | ATXS | Astria Therapeutics, Inc. | 710.14M | -0.24% | 999,894 | 706.00K |
| 191 | JBIO | Jade Biosciences, Inc. | 701.56M | 3.74% | 247,037 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 699.29M | 4.54% | 1,435,561 | 80.00M |
| 193 | PRME | Prime Medicine, Inc. | 688.68M | -2.26% | 2,584,515 | 5.98M |
| 194 | VOR | Vor Biopharma Inc. | 681.48M | 11.75% | 2,483,847 | - |
| 195 | TENX | Tenax Therapeutics, Inc. | 666.17M | 2.31% | 237,760 | - |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 659.62M | -3.04% | 366,028 | 282.08M |
| 197 | PROK | ProKidney Corp. | 643.79M | -6.55% | 1,351,041 | 744.00K |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 642.16M | 1.40% | 552,823 | - |
| 199 | IVVD | Invivyd, Inc. | 631.65M | -8.57% | 6,271,532 | 50.04M |
| 200 | ENGN | enGene Holdings Inc. | 609.56M | -2.26% | 596,529 | - |
| 201 | LENZ | LENZ Therapeutics, Inc. | 606.40M | 5.96% | 1,255,205 | 17.50M |
| 202 | GOSS | Gossamer Bio, Inc. | 601.79M | 3.17% | 3,944,971 | 44.05M |
| 203 | MGTX | MeiraGTx Holdings plc | 589.19M | -1.35% | 567,308 | 27.42M |
| 204 | EVMN | Evommune, Inc. | 580.04M | 9.52% | 212,253 | 13.00M |
| 205 | KROS | Keros Therapeutics, Inc. | 561.49M | -2.28% | 264,485 | 246.72M |
| 206 | DRTS | Alpha Tau Medical Ltd. | 550.81M | -9.27% | 822,482 | - |
| 207 | REPL | Replimune Group, Inc. | 549.89M | -0.43% | 1,947,915 | - |
| 208 | LBRX | LB Pharmaceuticals Inc | 543.93M | 7.66% | 217,627 | - |
| 209 | FBRX | Forte Biosciences, Inc. | 542.25M | -8.92% | 244,673 | - |
| 210 | CRMD | CorMedix Inc. | 542.07M | 1.47% | 2,335,218 | 214.30M |
| 211 | ANRO | Alto Neuroscience, Inc. | 541.18M | 1.46% | 220,305 | - |
| 212 | DSGN | Design Therapeutics, Inc. | 538.31M | 1.83% | 218,881 | - |
| 213 | LXEO | Lexeo Therapeutics, Inc. | 529.89M | -1.76% | 1,346,468 | - |
| 214 | OCGN | Ocugen, Inc. | 521.57M | -1.18% | 5,033,505 | 5.37M |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 515.31M | 7.89% | 1,013,542 | - |
| 216 | VSTM | Verastem, Inc. | 513.26M | -0.45% | 1,841,799 | 13.38M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 513.23M | -5.45% | 1,059,209 | 180.61M |
| 218 | ZVRA | Zevra Therapeutics, Inc. | 507.80M | 1.01% | 860,884 | 84.39M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 507.73M | 0.59% | 119,175 | 41.00K |
| 220 | PRTA | Prothena Corporation plc | 497.93M | -1.07% | 630,805 | 11.79M |
| 221 | NAGE | Niagen Bioscience, Inc. | 497.35M | 0.32% | 718,591 | 124.71M |
| 222 | ACRS | Aclaris Therapeutics, Inc. | 479.97M | 69.08% | 34,892,877 | 15.74M |
| 223 | LXRX | Lexicon Pharmaceuticals, Inc. | 476.05M | -4.38% | 1,645,561 | 70.86M |
| 224 | MNPR | Monopar Therapeutics Inc. | 469.92M | 0.01% | 289,742 | - |
| 225 | BCYC | Bicycle Therapeutics plc | 462.68M | 2.46% | 238,034 | 28.34M |
| 226 | ALT | Altimmune, Inc. | 461.73M | -0.24% | 4,514,429 | 20.00K |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.87M | 3.09% | 149,080 | - |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 455.64M | 3.21% | 1,146,143 | 212.07M |
| 229 | NBP | NovaBridge Biosciences | 451.94M | 5.09% | 1,329,374 | - |
| 230 | AVXL | Anavex Life Sciences Corp. | 449.42M | 0.40% | 1,708,855 | - |
| 231 | SLDB | Solid Biosciences Inc. | 437.86M | 2.74% | 548,532 | - |
| 232 | ABSI | Absci Corporation | 436.08M | -3.97% | 4,912,061 | 2.82M |
| 233 | ADCT | ADC Therapeutics SA | 436.05M | -2.76% | 357,791 | 75.21M |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 435.37M | 0.93% | 632,017 | 120.00K |
| 235 | CTNM | Contineum Therapeutics, Inc. | 432.87M | 0.94% | 137,529 | - |
| 236 | ASMB | Assembly Biosciences, Inc. | 423.90M | -8.75% | 268,090 | 37.19M |
| 237 | PRTC | PureTech Health plc | 423.69M | -5.61% | 10,237 | 6.39M |
| 238 | IMMP | Immutep Limited | 417.40M | -4.42% | 146,046 | 3.31M |
| 239 | PEPG | PepGen Inc. | 409.05M | 14.42% | 2,224,918 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 399.84M | -2.94% | 810,663 | 10.82M |
| 241 | VTVT | vTv Therapeutics Inc. | 397.95M | -9.89% | 20,347 | 17.00K |
| 242 | DMAC | DiaMedica Therapeutics Inc. | 397.55M | -2.11% | 481,952 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 393.93M | - | 1,941,470 | - |
| 244 | BNTC | Benitec Biopharma Inc. | 393.82M | -1.03% | 57,147 | - |
| 245 | HELP | Cybin Inc. | 383.26M | -0.78% | 368,442 | - |
| 246 | TRDA | Entrada Therapeutics, Inc. | 380.85M | -3.45% | 252,376 | 61.52M |
| 247 | AUTL | Autolus Therapeutics plc | 377.92M | 2.90% | 2,151,705 | 51.13M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 360.49M | -0.95% | 183,635 | 65.32M |
| 249 | TECX | Tectonic Therapeutic, Inc. | 357.48M | 1.60% | 259,504 | - |
| 250 | ALLO | Allogene Therapeutics, Inc. | 352.83M | -3.68% | 4,830,654 | 22.00K |
| 251 | AARD | Aardvark Therapeutics, Inc. | 337.92M | 0.98% | 290,518 | - |
| 252 | PBYI | Puma Biotechnology, Inc. | 332.58M | 3.61% | 647,413 | 212.00M |
| 253 | ACIU | AC Immune SA | 328.49M | -5.41% | 485,891 | 5.48M |
| 254 | FHTX | Foghorn Therapeutics Inc. | 326.30M | -7.48% | 250,065 | 24.52M |
| 255 | ZURA | Zura Bio Limited | 325.77M | 4.16% | 758,804 | - |
| 256 | CADL | Candel Therapeutics, Inc. | 325.00M | -7.50% | 1,206,197 | - |
| 257 | XOMA | XOMA Royalty Corporation | 323.32M | -0.99% | 710,874 | 47.11M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 320.89M | -1.08% | 327,732 | 33.98M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 317.78M | -7.43% | 1,210,224 | - |
| 260 | AURA | Aura Biosciences, Inc. | 315.61M | -1.00% | 217,624 | - |
| 261 | IMRX | Immuneering Corporation | 308.64M | 4.37% | 1,752,791 | - |
| 262 | TARA | Protara Therapeutics, Inc. | 300.09M | 11.78% | 1,077,568 | - |
| 263 | CLLS | Cellectis S.A. | 296.58M | 1.97% | 15,984 | 82.55M |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 294.96M | -14.43% | 667,466 | - |
| 265 | GUTS | Fractyl Health, Inc. | 292.94M | - | 3,838,255 | 3.00K |
| 266 | ACHV | Achieve Life Sciences, Inc. | 292.25M | -5.83% | 968,210 | - |
| 267 | RLMD | Relmada Therapeutics, Inc. | 288.93M | 5.35% | 829,005 | - |
| 268 | ABEO | Abeona Therapeutics Inc. | 287.76M | 1.14% | 1,390,653 | 400.00K |
| 269 | ALDX | Aldeyra Therapeutics, Inc. | 285.77M | 2.59% | 1,019,967 | - |
| 270 | PALI | Palisade Bio, Inc. | 281.62M | 13.86% | 14,255,214 | - |
| 271 | STTK | Shattuck Labs, Inc. | 274.63M | -6.47% | 525,827 | 1.00M |
| 272 | OABI | OmniAb, Inc. | 274.24M | 0.26% | 297,032 | 21.09M |
| 273 | AVTX | Avalo Therapeutics, Inc. | 273.99M | -1.73% | 418,837 | 192.00K |
| 274 | LRMR | Larimar Therapeutics, Inc. | 273.89M | 2.24% | 850,437 | - |
| 275 | CBIO | Crescent Biopharma, Inc. | 273.69M | 3.63% | 417,041 | - |
| 276 | NGNE | Neurogene Inc. | 271.38M | -0.17% | 78,516 | 925.00K |
| 277 | AVIR | Atea Pharmaceuticals, Inc. | 268.76M | 1.18% | 233,096 | - |
| 278 | RZLT | Rezolute, Inc. | 267.98M | 5.86% | 3,617,865 | - |
| 279 | HRTX | Heron Therapeutics, Inc. | 260.37M | -4.70% | 1,166,056 | 155.10M |
| 280 | NAUT | Nautilus Biotechnology, Inc. | 258.93M | 2.50% | 167,305 | - |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 252.39M | -2.44% | 98,209 | 38.79M |
| 282 | MENS | Jyong Biotech Ltd. | 250.69M | -2.10% | 704,215 | - |
| 283 | SLN | Silence Therapeutics plc | 245.62M | 3.17% | 341,540 | 25.83M |
| 284 | IMMX | Immix Biopharma, Inc. | 242.40M | -2.13% | 550,359 | - |
| 285 | ENLV | Enlivex Therapeutics Ltd. | 232.63M | 4.26% | 382,363 | - |
| 286 | CAMP | Camp4 Therapeutics Corporation | 230.35M | -21.00% | 138,432 | 3.80M |
| 287 | OBIO | Orchestra BioMed Holdings, Inc. | 228.12M | -4.27% | 137,592 | 2.82M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 225.69M | -1.20% | 311,415 | 1.00 |
| 289 | MDWD | MediWound Ltd. | 217.96M | 4.62% | 165,012 | 20.93M |
| 290 | ARMP | Armata Pharmaceuticals, Inc. | 215.16M | -7.66% | 58,625 | 5.05M |
| 291 | CCCC | C4 Therapeutics, Inc. | 211.27M | -2.24% | 10,034,419 | 30.11M |
| 292 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.15M | -0.58% | 455,161 | 10.30M |
| 293 | CABA | Cabaletta Bio, Inc. | 210.82M | -0.45% | 2,493,870 | - |
| 294 | NVCT | Nuvectis Pharma, Inc. | 207.74M | -4.36% | 50,753 | - |
| 295 | CLYM | Climb Bio, Inc. | 206.26M | 2.37% | 471,875 | - |
| 296 | SGMT | Sagimet Biosciences Inc. | 204.24M | 2.28% | 501,053 | - |
| 297 | MIST | Milestone Pharmaceuticals Inc. | 204.18M | -1.95% | 1,797,990 | - |
| 298 | VYGR | Voyager Therapeutics, Inc. | 204.05M | -2.39% | 916,440 | 31.32M |
| 299 | CGEN | Compugen Ltd. | 203.91M | -7.63% | 633,604 | 6.90M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 201.74M | -2.61% | 498,301 | 97.60M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 200.86M | 3.74% | 10,514 | 18.97M |
| 302 | ALEC | Alector, Inc. | 199.75M | -0.54% | 1,179,215 | 69.05M |
| 303 | OVID | Ovid Therapeutics Inc. | 197.88M | -3.18% | 1,275,857 | 6.61M |
| 304 | TLSA | Tiziana Life Sciences Ltd | 197.85M | -5.95% | 806,796 | - |
| 305 | EDIT | Editas Medicine, Inc. | 197.19M | -0.49% | 1,736,569 | 46.38M |
| 306 | HUMA | Humacyte, Inc. | 196.86M | -8.11% | 4,865,707 | 1.57M |
| 307 | GALT | Galectin Therapeutics Inc. | 192.77M | -1.64% | 382,175 | - |
| 308 | SABS | SAB Biotherapeutics, Inc. | 190.90M | 0.75% | 525,811 | 114.70K |
| 309 | QNCX | Quince Therapeutics, Inc. | 190.43M | -3.66% | 1,549,227 | - |
| 310 | CRDF | Cardiff Oncology, Inc. | 189.28M | -2.43% | 529,351 | 501.00K |
| 311 | NERV | Minerva Neurosciences, Inc. | 189.11M | -1.80% | 51,236 | - |
| 312 | RNAC | Cartesian Therapeutics, Inc. | 188.01M | -2.56% | 90,166 | 1.09M |
| 313 | CHRS | Coherus Oncology, Inc. | 187.35M | -3.13% | 1,262,583 | 277.73M |
| 314 | ZNTL | Zentalis Pharmaceuticals, Inc. | 185.83M | -3.04% | 786,616 | 26.87M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 183.47M | 0.72% | 62,857 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 176.98M | 1.82% | 281,615 | 18.86M |
| 317 | ELDN | Eledon Pharmaceuticals, Inc. | 175.37M | 4.25% | 836,663 | - |
| 318 | IPSC | Century Therapeutics, Inc. | 167.64M | -11.52% | 3,501,093 | 113.34M |
| 319 | IPHA | Innate Pharma S.A. | 166.67M | 2.70% | 62,924 | 14.84M |
| 320 | RANI | Rani Therapeutics Holdings, Inc. | 165.27M | -2.16% | 744,260 | 1.20M |
| 321 | VXRT | Vaxart, Inc. | 165.17M | -1.92% | 695,839 | 148.20M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 164.86M | 0.49% | 422,888 | 61.84M |
| 323 | NTHI | NeOnc Technologies Holdings, Inc. | 162.81M | -4.24% | 20,679 | 59.99K |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 159.16M | 3.25% | 139,625 | - |
| 325 | IRD | Opus Genetics, Inc. | 155.86M | 7.62% | 525,571 | 14.63M |
| 326 | SRZN | Surrozen, Inc. | 154.11M | -10.10% | 64,835 | 3.60M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 152.03M | -3.74% | 3,521,953 | - |
| 328 | PRLD | Prelude Therapeutics Incorporated | 151.61M | 1.66% | 309,101 | 10.50M |
| 329 | MOLN | Molecular Partners AG | 151.55M | -3.57% | 10,504 | 856.30K |
| 330 | CDXS | Codexis, Inc. | 145.42M | -3.59% | 526,463 | 52.93M |
| 331 | NKTX | Nkarta, Inc. | 144.90M | - | 356,757 | - |
| 332 | CNTX | Context Therapeutics Inc. | 141.49M | 6.94% | 3,623,707 | - |
| 333 | UNCY | Unicycive Therapeutics, Inc. | 141.41M | 6.30% | 778,003 | - |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 140.10M | -4.35% | 336,089 | 2.00M |
| 335 | ELTX | Elicio Therapeutics, Inc. | 138.93M | -3.52% | 68,063 | - |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 136.74M | -6.25% | 1,623,641 | 70.00M |
| 337 | MCRB | Seres Therapeutics, Inc. | 136.24M | -5.64% | 42,789 | 351.00K |
| 338 | TTRX | Turn Therapeutics Inc. | 136.04M | 1.32% | 49,200 | - |
| 339 | WHWK | Whitehawk Therapeutics, Inc. | 134.79M | -1.72% | 114,561 | 14.38M |
| 340 | SPRO | Spero Therapeutics, Inc. | 134.09M | -1.24% | 275,819 | 40.55M |
| 341 | CRBU | Caribou Biosciences, Inc. | 129.92M | -4.79% | 1,542,516 | 9.30M |
| 342 | ACTU | Actuate Therapeutics, Inc. | 129.23M | -2.28% | 24,539 | - |
| 343 | CNTB | Connect Biopharma Holdings Limited | 128.58M | 6.48% | 66,404 | 762.00K |
| 344 | STRO | Sutro Biopharma, Inc. | 127.11M | 7.96% | 201,455 | 105.65M |
| 345 | VRCA | Verrica Pharmaceuticals Inc. | 126.96M | 9.37% | 392,969 | 30.83M |
| 346 | FATE | Fate Therapeutics, Inc. | 126.89M | -7.56% | 1,956,687 | 7.14M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 123.58M | -4.11% | 1,221,551 | - |
| 348 | SGMO | Sangamo Therapeutics, Inc. | 123.16M | -8.82% | 8,711,488 | 32.88M |
| 349 | ACOG | Alpha Cognition Inc. | 121.32M | -2.45% | 133,022 | 7.43M |
| 350 | GNLX | Genelux Corporation | 120.90M | -0.36% | 289,531 | 8.00K |
| 351 | THAR | Tharimmune, Inc. | 115.43M | - | 563,920 | - |
| 352 | AGEN | Agenus Inc. | 114.61M | 0.90% | 850,806 | 106.83M |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 113.40M | 4.52% | 196,063 | 251.00K |
| 354 | ABOS | Acumen Pharmaceuticals, Inc. | 112.67M | -1.59% | 73,180 | - |
| 355 | RPTX | Repare Therapeutics Inc. | 111.22M | - | 4,156,248 | 11.87M |
| 356 | MGNX | MacroGenics, Inc. | 110.70M | 1.74% | 1,172,887 | 127.63M |
| 357 | KPTI | Karyopharm Therapeutics Inc. | 108.95M | -5.71% | 424,238 | 142.53M |
| 358 | FBIO | Fortress Biotech, Inc. | 108.01M | -6.45% | 847,870 | 62.30M |
| 359 | ONCY | Oncolytics Biotech Inc. | 106.59M | -1.92% | 1,101,089 | - |
| 360 | SEER | Seer, Inc. | 104.63M | -1.59% | 83,318 | 16.38M |
| 361 | ANIX | Anixa Biosciences, Inc. | 103.80M | -2.51% | 225,417 | - |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 103.74M | -0.66% | 945,874 | 182.34K |
| 363 | PYXS | Pyxis Oncology, Inc. | 103.36M | -5.68% | 610,040 | 2.82M |
| 364 | DTIL | Precision BioSciences, Inc. | 100.38M | 2.96% | 198,411 | 698.00K |
| 365 | VANI | Vivani Medical, Inc. | 99.22M | 7.09% | 798,123 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 97.57M | -2.13% | 1,143,671 | - |
| 367 | CSBR | Champions Oncology, Inc. | 97.20M | -2.91% | 3,162 | 58.42M |
| 368 | ETHZ | ETHZilla Corporation | 96.58M | -9.12% | 840,286 | 4.11M |
| 369 | SAVA | Cassava Sciences, Inc. | 96.13M | -2.45% | 854,267 | - |
| 370 | COYA | Coya Therapeutics, Inc. | 93.74M | 4.67% | 353,786 | 3.99M |
| 371 | CBUS | Cibus, Inc. | 92.45M | -10.26% | 492,176 | 3.79M |
| 372 | EXOZ | eXoZymes, Inc. | 91.98M | 4.19% | 5,668 | -700.00 |
| 373 | HYFT | MindWalk Holdings Corp. | 91.05M | -5.80% | 452,798 | 19.02M |
| 374 | MREO | Mereo BioPharma Group plc | 89.93M | -11.70% | 11,662,161 | 500.00K |
| 375 | ADAG | Adagene Inc. | 88.14M | -4.59% | 17,299 | 103.20K |
| 376 | DWTX | Dogwood Therapeutics, Inc. | 87.91M | -1.44% | 26,524 | - |
| 377 | MAIA | MAIA Biotechnology, Inc. | 84.18M | 26.44% | 4,572,060 | - |
| 378 | MNOV | MediciNova, Inc. | 82.57M | 5.00% | 74,628 | 257.92K |
| 379 | OKYO | OKYO Pharma Limited | 80.86M | -2.71% | 166,280 | - |
| 380 | CALC | CalciMedica, Inc. | 80.69M | 9.16% | 54,290 | - |
| 381 | KRRO | Korro Bio, Inc. | 80.24M | -2.96% | 147,473 | 7.37M |
| 382 | ACET | Adicet Bio, Inc. | 79.84M | -4.59% | 308,373 | - |
| 383 | PLRX | Pliant Therapeutics, Inc. | 78.66M | -0.78% | 722,904 | - |
| 384 | ATOS | Atossa Therapeutics, Inc. | 77.89M | -1.95% | 3,944,748 | - |
| 385 | IMUX | Immunic, Inc. | 77.55M | 4.32% | 1,935,597 | - |
| 386 | XBIT | XBiotech Inc. | 77.13M | -1.56% | 72,655 | - |
| 387 | KZIA | Kazia Therapeutics Limited | 76.71M | -1.68% | 112,291 | 1.20M |
| 388 | GANX | Gain Therapeutics, Inc. | 76.54M | 9.94% | 1,129,780 | - |
| 389 | SPRB | Spruce Biosciences, Inc. | 76.49M | -2.82% | 17,731 | 697.00K |
| 390 | PYPD | PolyPid Ltd. | 74.19M | 2.06% | 83,192 | - |
| 391 | ANVS | Annovis Bio, Inc. | 73.94M | -3.46% | 649,466 | - |
| 392 | ENTX | Entera Bio Ltd. | 72.00M | -3.09% | 133,504 | 124.00K |
| 393 | ALXO | ALX Oncology Holdings Inc. | 71.57M | 12.82% | 280,236 | - |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.23M | -2.41% | 83,608 | 501.00K |
| 395 | EQ | Equillium, Inc. | 70.03M | - | 441,114 | 4.39M |
| 396 | BYSI | BeyondSpring Inc. | 69.91M | -0.58% | 64,802 | 1.88M |
| 397 | ATYR | aTyr Pharma, Inc. | 69.23M | -0.30% | 858,740 | 190.00K |
| 398 | PTHS | Pelthos Therapeutics Inc. | 68.99M | -3.08% | 13,433 | 7.41M |
| 399 | ANL | Adlai Nortye Ltd. | 67.53M | 1.67% | 65,748 | -1.35M |
| 400 | IMA | ImageneBio, Inc. | 67.10M | -3.52% | 93,063 | 800.00K |
| 401 | IFRX | InflaRx N.V. | 67.00M | -1.10% | 1,148,939 | 73.73K |
| 402 | CRVO | CervoMed Inc. | 64.68M | -3.98% | 94,327 | 6.16M |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 64.54M | -3.96% | 1,030,643 | 242.00K |
| 404 | TVGN | Tevogen Bio Holdings Inc. | 64.09M | -5.33% | 351,147 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 63.56M | -0.88% | 518,490 | 8.42M |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 61.85M | -1.01% | 2,148,952 | - |
| 407 | MGX | Metagenomi Therapeutics, Inc. | 60.45M | -3.01% | 332,361 | 30.91M |
| 408 | ICCC | ImmuCell Corporation | 58.98M | 2.52% | 14,316 | 27.77M |
| 409 | ATHE | Alterity Therapeutics Limited | 58.67M | -4.35% | 7,234 | 3.57M |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 57.47M | -4.42% | 411,590 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 57.36M | -2.53% | 71,810 | 8.20M |
| 412 | NTRB | Nutriband Inc. | 55.92M | 5.50% | 28,742 | 2.28M |
| 413 | INKT | MiNK Therapeutics, Inc. | 55.48M | -1.17% | 10,446 | - |
| 414 | GRCE | Grace Therapeutics, Inc. | 55.24M | -2.19% | 249,245 | - |
| 415 | LPCN | Lipocine Inc. | 55.08M | -10.87% | 129,835 | 4.32M |
| 416 | OSTX | OS Therapies Incorporated | 52.82M | 2.74% | 930,527 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 51.77M | -0.56% | 669,642 | - |
| 418 | ABVC | ABVC BioPharma, Inc. | 50.68M | 6.44% | 45,506 | 797.92K |
| 419 | PSTV | Plus Therapeutics, Inc. | 50.45M | -0.90% | 14,732,069 | 5.26M |
| 420 | IBIO | iBio, Inc. | 50.37M | 1.82% | 1,357,877 | 500.00K |
| 421 | NRXS | NeurAxis, Inc. | 49.54M | 1.75% | 133,403 | 3.36M |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.29M | 0.88% | 83,628 | 2.65M |
| 423 | QTTB | Q32 Bio Inc. | 48.36M | 9.17% | 365,337 | - |
| 424 | LITS | Lite Strategy, Inc. | 48.17M | -8.39% | 515,933 | - |
| 425 | TIL | Instil Bio, Inc. | 48.02M | 0.14% | 114,733 | - |
| 426 | IBO | Impact BioMedical Inc. | 48.00M | 1.62% | 35,274 | 25.00K |
| 427 | NXTC | NextCure, Inc. | 47.15M | 4.18% | 20,848 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -4.32% | 178,725 | - |
| 429 | KZR | Kezar Life Sciences, Inc. | 45.04M | -0.81% | 25,223 | - |
| 430 | ANEB | Anebulo Pharmaceuticals, Inc. | 44.78M | - | 161,351 | - |
| 431 | GLTO | Galecto, Inc. | 44.61M | 11.79% | 42,606 | - |
| 432 | CVM | CEL-SCI Corporation | 44.15M | 1.94% | 95,648 | - |
| 433 | TVRD | Tvardi Therapeutics, Inc. | 43.44M | 1.31% | 54,893 | - |
| 434 | APLM | Apollomics, Inc. | 43.20M | -2.99% | 26,306 | 6.93M |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.10M | 0.65% | 619,155 | - |
| 436 | INMB | INmune Bio, Inc. | 42.54M | -7.51% | 413,369 | 50.00K |
| 437 | CING | Cingulate Inc. | 42.39M | 5.17% | 570,458 | - |
| 438 | XLO | Xilio Therapeutics, Inc. | 42.28M | -2.20% | 433,464 | 31.80M |
| 439 | HURA | TuHURA Biosciences, Inc. | 41.34M | -10.48% | 273,356 | - |
| 440 | PASG | Passage Bio, Inc. | 40.59M | -0.78% | 66,299 | - |
| 441 | VERU | Veru Inc. | 40.45M | -6.32% | 186,000 | 16.89M |
| 442 | OKUR | OnKure Therapeutics, Inc. | 40.31M | -0.83% | 39,000 | - |
| 443 | LTRN | Lantern Pharma Inc. | 40.15M | 4.97% | 126,383 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 39.93M | -3.76% | 159,927 | 90.00K |
| 445 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.47M | -6.11% | 4,409,603 | - |
| 446 | XCUR | Exicure, Inc. | 39.14M | -1.29% | 36,753 | 500.00K |
| 447 | EVAX | Evaxion A/S | 39.03M | 2.86% | 50,937 | 7.65M |
| 448 | ESLA | Estrella Immunopharma, Inc. | 38.29M | -8.35% | 69,355 | - |
| 449 | RNXT | RenovoRx, Inc. | 38.12M | 1.96% | 176,103 | 928.00K |
| 450 | CELU | Celularity Inc. | 38.07M | 0.76% | 39,502 | 40.58M |
| 451 | GBIO | Generation Bio Co. | 37.73M | -0.53% | 111,153 | 15.27M |
| 452 | IOBT | IO Biotech, Inc. | 37.10M | 2.69% | 664,753 | - |
| 453 | MRKR | Marker Therapeutics, Inc. | 35.35M | 17.13% | 983,343 | 4.69M |
| 454 | KYNB | Kyntra Bio, Inc. | 34.59M | -6.46% | 47,905 | 8.30M |
| 455 | OTLK | Outlook Therapeutics, Inc. | 33.34M | -4.80% | 2,168,681 | 1.41M |
| 456 | ANTX | AN2 Therapeutics, Inc. | 32.33M | -1.67% | 105,758 | - |
| 457 | DYAI | Dyadic International, Inc. | 32.04M | 1.77% | 26,054 | 3.34M |
| 458 | GNTA | Genenta Science S.p.A. | 31.63M | 3.85% | 71,367 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 31.54M | -0.83% | 350,613 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 31.19M | -2.71% | 165,441 | - |
| 461 | ATRA | Atara Biotherapeutics, Inc. | 31.15M | -4.85% | 597,618 | 151.93M |
| 462 | BCTX | BriaCell Therapeutics Corp. | 31.07M | 1.86% | 636,722 | - |
| 463 | JUNS | Jupiter Neurosciences, Inc. | 30.98M | 4.81% | 43,808 | - |
| 464 | PLUR | Pluri Inc. | 30.73M | -4.35% | 1,795 | 1.33M |
| 465 | SER | Serina Therapeutics, Inc. | 30.61M | -7.42% | 46,597 | 116.00K |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 30.29M | 7.33% | 377,966 | - |
| 467 | PTN | Palatin Technologies, Inc. | 29.89M | -4.22% | 20,313 | 8.85M |
| 468 | BRNS | Barinthus Biotherapeutics plc | 29.40M | -0.70% | 42,426 | 14.97M |
| 469 | SNTI | Senti Biosciences, Inc. | 28.13M | 3.88% | 539,016 | - |
| 470 | DARE | Daré Bioscience, Inc. | 28.01M | 1.55% | 86,263 | -57.13K |
| 471 | QNTM | Quantum BioPharma Ltd. | 27.54M | 2.41% | 82,548 | - |
| 472 | BOLD | Boundless Bio, Inc. | 27.53M | -0.81% | 599,215 | - |
| 473 | HOWL | Werewolf Therapeutics, Inc. | 27.40M | 2.75% | 672,885 | 1.14M |
| 474 | CUE | Cue Biopharma, Inc. | 27.27M | -1.03% | 740,646 | 7.10M |
| 475 | IGC | IGC Pharma, Inc. | 26.84M | -5.47% | 554,381 | 1.11M |
| 476 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.49M | -8.43% | 109,193 | - |
| 477 | RLYB | Rallybio Corporation | 25.98M | -6.36% | 318,597 | 674.00K |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 25.48M | -2.80% | 1,021,652 | 721.00K |
| 479 | LONA | LeonaBio, Inc. | 24.49M | 1.80% | 94,100 | - |
| 480 | NNVC | NanoViricides, Inc. | 24.37M | -4.24% | 222,798 | - |
| 481 | HYPD | Hyperion DeFi, Inc. | 24.10M | -11.96% | 436,139 | 345.32K |
| 482 | INTS | Intensity Therapeutics, Inc. | 23.98M | -2.20% | 2,634,285 | - |
| 483 | PLRZ | Polyrizon Ltd. | 23.26M | -6.17% | 49,346 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 22.87M | -5.18% | 332,105 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 21.67M | -1.95% | 69,574 | 15.65M |
| 486 | FBLG | FibroBiologics, Inc. | 21.45M | -3.70% | 564,508 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.41M | 0.18% | 156,330 | - |
| 488 | TRAW | Traws Pharma, Inc. | 20.62M | 27.72% | 896,439 | 2.85M |
| 489 | BCAB | BioAtla, Inc. | 20.35M | -0.50% | 1,588,033 | 11.00M |
| 490 | CASI | CASI Pharmaceuticals, Inc. | 20.34M | 3.45% | 29,309 | 26.85M |
| 491 | LNAI | Lunai Bioworks Inc. | 20.29M | -6.38% | 123,038 | - |
| 492 | ALLR | Allarity Therapeutics, Inc. | 20.14M | -1.69% | 106,753 | - |
| 493 | LIMN | Liminatus Pharma, Inc. | 19.76M | -5.08% | 116,872 | - |
| 494 | VYNE | VYNE Therapeutics Inc. | 19.10M | 1.25% | 250,384 | 524.00K |
| 495 | LSTA | Lisata Therapeutics, Inc. | 19.05M | - | 37,522 | 1.07M |
| 496 | CLGN | CollPlant Biotechnologies Ltd. | 18.78M | -2.00% | 14,665 | 2.48M |
| 497 | OSRH | OSR Holdings, Inc. | 18.45M | -3.80% | 1,356,447 | -90.52K |
| 498 | LEXX | Lexaria Bioscience Corp. | 18.31M | -3.04% | 81,114 | 522.00K |
| 499 | KAPA | Kairos Pharma, Ltd. | 18.21M | 0.25% | 67,268 | - |
| 500 | PMN | ProMIS Neurosciences, Inc. | 17.57M | -0.19% | 10,848 | - |
| 501 | ITRM | Iterum Therapeutics plc | 17.40M | -3.20% | 327,598 | 390.00K |
| 502 | CVKD | Cadrenal Therapeutics, Inc. | 17.23M | -6.35% | 28,748 | - |
| 503 | KALA | KALA BIO, Inc. | 17.02M | -10.73% | 1,018,115 | - |
| 504 | CTXR | Citius Pharmaceuticals, Inc. | 16.84M | -5.49% | 433,082 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.60M | 2.88% | 281,499 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.25M | -0.30% | 8,693,409 | 1.00M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 14.84M | -2.51% | 63,418 | - |
| 508 | COCP | Cocrystal Pharma, Inc. | 14.47M | -5.41% | 188,117 | - |
| 509 | AEON | AEON Biopharma, Inc. | 14.21M | 5.26% | 514,399 | - |
| 510 | SNGX | Soligenix, Inc. | 13.92M | -2.13% | 146,491 | 2.34K |
| 511 | BCDA | BioCardia, Inc. | 13.80M | -7.14% | 101,342 | 3.00K |
| 512 | NCNA | NuCana plc | 13.36M | -3.02% | 70,572 | - |
| 513 | MBRX | Moleculin Biotech, Inc. | 13.12M | 2.40% | 150,353 | - |
| 514 | TPST | Tempest Therapeutics, Inc. | 12.71M | -5.15% | 36,185 | - |
| 515 | CRIS | Curis, Inc. | 12.52M | -2.76% | 289,251 | 11.65M |
| 516 | BLRX | BioLineRx Ltd. | 12.38M | -1.74% | 6,225 | 12.74M |
| 517 | EDSA | Edesa Biotech, Inc. | 12.17M | - | 20,371 | - |
| 518 | SNSE | Sensei Biotherapeutics, Inc. | 12.12M | -7.95% | 49,454 | - |
| 519 | GDTC | CytoMed Therapeutics Limited | 12.12M | 10.13% | 12,484 | 573.19K |
| 520 | AKTX | Akari Therapeutics, Plc | 12.08M | -5.95% | 92,247 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 12.05M | -1.26% | 7,084 | 5.20M |
| 522 | IMNN | Imunon, Inc. | 11.77M | -3.08% | 20,961 | - |
| 523 | PHIO | Phio Pharmaceuticals Corp. | 11.63M | -5.26% | 1,355,500 | - |
| 524 | LGVN | Longeveron Inc. | 11.33M | -3.80% | 199,375 | 1.44M |
| 525 | NCEL | NewcelX Ltd. | 11.30M | 5.08% | 82,172 | - |
| 526 | GRDX | GridAI Technologies Corp. | 11.03M | -16.33% | 169,752 | - |
| 527 | INAB | IN8bio, Inc. | 9.96M | -8.88% | 136,928 | - |
| 528 | BRTX | BioRestorative Therapies, Inc. | 9.94M | -2.61% | 15,402 | 383.40K |
| 529 | APVO | Aptevo Therapeutics Inc. | 9.81M | 4.02% | 130,875 | - |
| 530 | PULM | Pulmatrix, Inc. | 9.75M | 1.71% | 5,686 | 3.00K |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 9.73M | -4.82% | 85,514 | - |
| 532 | MTVA | MetaVia Inc. | 9.62M | -3.54% | 170,332 | - |
| 533 | ERNA | Ernexa Therapeutics Inc. | 9.58M | 0.83% | 2,616,357 | 1,000.00 |
| 534 | ALZN | Alzamend Neuro, Inc. | 9.20M | 2.98% | 83,371 | - |
| 535 | BIVI | BioVie Inc. | 9.20M | 1.24% | 96,723 | - |
| 536 | IMRN | Immuron Limited | 9.00M | -7.83% | 73,053 | 4.78M |
| 537 | EVGN | Evogene Ltd. | 8.77M | -3.81% | 16,406 | 8.02M |
| 538 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.77M | 1.75% | 22,508 | - |
| 539 | PMCB | PharmaCyte Biotech, Inc. | 8.67M | -3.90% | 118,433 | - |
| 540 | ABP | Abpro Holdings, Inc. | 8.39M | -11.71% | 9,264 | 183.00K |
| 541 | APM | Aptorum Group Limited | 8.31M | -0.97% | 15,907 | - |
| 542 | ICU | SeaStar Medical Holding Corporation | 8.22M | -9.88% | 142,444 | 881.00K |
| 543 | KPRX | Kiora Pharmaceuticals, Inc. | 8.11M | 2.31% | 12,791 | 20.00K |
| 544 | XTLB | XTL Biopharmaceuticals Ltd. | 8.08M | -1.95% | 156,039 | 968.00K |
| 545 | RNAZ | TransCode Therapeutics, Inc. | 8.01M | -2.24% | 13,743 | - |
| 546 | ADXN | Addex Therapeutics Ltd | 7.79M | -1.20% | 11,024 | 198.82K |
| 547 | GTBP | GT Biopharma, Inc. | 7.71M | -2.75% | 811,978 | - |
| 548 | MBIO | Mustang Bio, Inc. | 7.52M | -1.90% | 22,631 | - |
| 549 | CLDI | Calidi Biotherapeutics, Inc. | 7.39M | -1.94% | 189,067 | - |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 7.34M | -8.47% | 121,761 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 7.17M | -8.56% | 35,920 | 81.00K |
| 552 | SLXN | Silexion Therapeutics Corp | 7.00M | -1.32% | 16,653 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 6.92M | -1.00% | 102,674 | 6.00K |
| 554 | SYBX | Synlogic, Inc. | 6.55M | -50.00% | 3,573,202 | 8.00K |
| 555 | GNPX | Genprex, Inc. | 6.54M | -6.00% | 777,397 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 6.49M | -5.52% | 14,553 | 6.00K |
| 557 | PPBT | Purple Biotech Ltd | 6.47M | -4.38% | 344,726 | - |
| 558 | TOVX | Theriva Biologics, Inc. | 6.45M | -7.27% | 4,697,840 | - |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.12M | -1.62% | 24,726 | 488.24K |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.01M | -3.87% | 535,252 | - |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 5.99M | -3.77% | 50,241 | - |
| 562 | XBIO | Xenetic Biosciences, Inc. | 5.73M | 3.48% | 56,906 | 2.86M |
| 563 | REVB | Revelation Biosciences, Inc. | 5.53M | -1.56% | 62,038 | - |
| 564 | ASBP | Aspire Biopharma Holdings, Inc. | 5.40M | - | 1,764,793 | 1.94K |
| 565 | VIVS | VivoSim Labs, Inc. | 5.37M | -1.44% | 10,539 | 140.00K |
| 566 | CANF | Can-Fite BioPharma Ltd. | 5.30M | -0.25% | 233,195 | 560.00K |
| 567 | DCOY | Decoy Therapeutics Inc. | 5.21M | -10.40% | 564,650 | - |
| 568 | CYCN | Cyclerion Therapeutics, Inc. | 5.14M | -0.74% | 36,384 | 2.86M |
| 569 | INDP | Indaptus Therapeutics, Inc. | 5.06M | -15.74% | 177,813 | - |
| 570 | SILO | Silo Pharma, Inc. | 4.81M | -4.29% | 102,543 | 72.10K |
| 571 | GOVX | GeoVax Labs, Inc. | 4.79M | -6.69% | 198,795 | 3.35M |
| 572 | CNSP | CNS Pharmaceuticals, Inc. | 4.51M | 3.27% | 31,185 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.39M | 3.88% | 67,988 | - |
| 574 | PBM | Psyence Biomedical Ltd. | 4.28M | - | 81,091 | - |
| 575 | PHGE | BiomX Inc. | 4.20M | 2.61% | 56,744 | - |
| 576 | LYRA | Lyra Therapeutics, Inc. | 4.15M | 17.59% | 338,061 | 600.00K |
| 577 | ENVB | Enveric Biosciences, Inc. | 4.13M | 3.06% | 64,941 | - |
| 578 | MTNB | Matinas BioPharma Holdings, Inc. | 4.08M | -7.62% | 21,224 | - |
| 579 | OGEN | Oragenics, Inc. | 4.04M | 2.11% | 27,316 | - |
| 580 | XRTX | XORTX Therapeutics Inc. | 4.02M | -1.17% | 62,237 | - |
| 581 | PPCB | Propanc Biopharma, Inc. | 3.99M | -4.69% | 1,467,742 | - |
| 582 | CMND | Clearmind Medicine Inc. | 3.96M | 5.60% | 76,039 | - |
| 583 | JAGX | Jaguar Health, Inc. | 3.88M | -40.21% | 7,911,753 | 11.79M |
| 584 | ELAB | PMGC Holdings Inc. | 3.84M | 1.89% | 298,587 | 285.95K |
| 585 | HCWB | HCW Biologics Inc. | 3.65M | -2.17% | 74,296 | 422.03K |
| 586 | SPRC | SciSparc Ltd. | 3.60M | 2.80% | 230,899 | 1.31M |
| 587 | ENSC | Ensysce Biosciences, Inc. | 3.41M | 11.53% | 207,650 | 4.49M |
| 588 | ARTL | Artelo Biosciences, Inc. | 3.35M | -2.92% | 28,239 | - |
| 589 | GRI | GRI Bio, Inc. | 3.24M | 4.63% | 3,708,556 | - |
| 590 | AZTR | Azitra, Inc. | 3.21M | -8.84% | 1,454,304 | 7.50K |
| 591 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.20M | -3.31% | 50,788 | 15.78K |
| 592 | BBLG | Bone Biologics Corporation | 3.11M | -2.81% | 17,533 | - |
| 593 | SCNI | Scinai Immunotherapeutics Ltd. | 3.00M | 0.02% | 15,855 | 1.15M |
| 594 | ONCO | Onconetix, Inc. | 2.72M | 7.69% | 826,009 | 1.22M |
| 595 | CDT | CDT Equity Inc. | 2.55M | 3.52% | 1,004,005 | - |
| 596 | DRMA | Dermata Therapeutics, Inc. | 2.55M | -5.65% | 1,955,558 | - |
| 597 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.13M | -17.62% | 501,172 | 1.36M |
| 598 | VRAX | Virax Biolabs Group Limited | 2.12M | -6.54% | 314,601 | 2.99K |
| 599 | ADTX | Aditxt, Inc. | 2.10M | 35.63% | 39,266,131 | 5.95K |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.85M | -1.34% | 213,684 | 104.90K |
| 601 | MLEC | Moolec Science SA | 1.17M | -13.07% | 107,644 | 7.83M |